Detalles de la búsqueda
1.
Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral blood.
Invest New Drugs
; 38(5): 1618-1626, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198648
2.
Intratumoral Treatment of Melanoma Tumors with Large Surface Area Microparticle Paclitaxel and Synergy with Immune Checkpoint Inhibition.
Int J Nanomedicine
; 19: 689-697, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38283196
3.
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies.
Oncol Ther
; 12(1): 31-55, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38289576
4.
Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome.
Pancreas
; 52(3): e179-e187, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782888
5.
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts.
Cancers (Basel)
; 11(4)2019 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022918
6.
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.
Cancer Chemother Pharmacol
; 75(5): 1075-87, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25898813
7.
Angiotensin 1 - 7 stimulation of platelet recovery.
Expert Opin Investig Drugs
; 23(4): 551-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24555825
Resultados
1 -
7
de 7
1
Próxima >
>>